[go: up one dir, main page]

AR247404A1 - Composicion peptidica de uso exclusivo para el diagnostico de la enfermedad de la malaria y procedimiento de sintesis de dicha composicion peptidica - Google Patents

Composicion peptidica de uso exclusivo para el diagnostico de la enfermedad de la malaria y procedimiento de sintesis de dicha composicion peptidica

Info

Publication number
AR247404A1
AR247404A1 AR86304136A AR30413686A AR247404A1 AR 247404 A1 AR247404 A1 AR 247404A1 AR 86304136 A AR86304136 A AR 86304136A AR 30413686 A AR30413686 A AR 30413686A AR 247404 A1 AR247404 A1 AR 247404A1
Authority
AR
Argentina
Prior art keywords
preparation
detection
well
peptide composition
composition useful
Prior art date
Application number
AR86304136A
Other languages
English (en)
Original Assignee
Eniricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eniricerche Spa filed Critical Eniricerche Spa
Application granted granted Critical
Publication of AR247404A1 publication Critical patent/AR247404A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10—Alpha-amino-carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

COMPOSICION PEPTIDA DE USO EXCLUSIVO PARA EL DIAGNOSTICO DE LA ENFERMEDAD DE LA MALARIA, CONSISTENTE EN UNA MEZCLA PEPTIDA DEFINIDA POR LA FORMULA I: EN LA CUAL ASN ES ASPARGINA; ALA ES ALAMINA;PRO ES PROLINA Y SIENDO N COMPRENDIDO ENTRE 10 Y 100.
AR86304136A 1985-07-25 1986-05-28 Composicion peptidica de uso exclusivo para el diagnostico de la enfermedad de la malaria y procedimiento de sintesis de dicha composicion peptidica AR247404A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21718/85A IT1187710B (it) 1985-07-25 1985-07-25 Composizione peptidica utile per la preparazione di vaccini per la malaria e di kit diagnostici per la determinazione di affezioni malariche

Publications (1)

Publication Number Publication Date
AR247404A1 true AR247404A1 (es) 1994-12-29

Family

ID=11185878

Family Applications (1)

Application Number Title Priority Date Filing Date
AR86304136A AR247404A1 (es) 1985-07-25 1986-05-28 Composicion peptidica de uso exclusivo para el diagnostico de la enfermedad de la malaria y procedimiento de sintesis de dicha composicion peptidica

Country Status (10)

Country Link
EP (1) EP0209643B1 (es)
JP (1) JPH0772198B2 (es)
AR (1) AR247404A1 (es)
AT (1) ATE77957T1 (es)
BR (1) BR8603729A (es)
CA (1) CA1339590C (es)
DE (1) DE3685917T2 (es)
ES (1) ES8707262A1 (es)
IN (1) IN162809B (es)
IT (1) IT1187710B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225530A (en) * 1986-07-16 1993-07-06 Eniricerche S.P.A. Polypeptide useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of malarial affections
IT1196501B (it) * 1986-07-16 1988-11-16 Eniricerche Spa Polipeptide utile per la preparazione di vaccini per la malaria e di kits diagnostici per la determinazione di affezioni malariche
IT1198233B (it) * 1986-12-23 1988-12-21 Eniricerche Spa Metodo per la determinazione di anticorpi antisporozoita di p. falciparum nel sangue umano
CA1329124C (en) * 1987-02-02 1994-05-03 Jerald C. Sadoff Conjugate malaria vaccine
IT1223301B (it) * 1987-09-11 1990-09-19 Eniricerche Spa Polipeptidi sequenziali immunologicamente attivi
IT1226728B (it) * 1988-08-05 1991-02-05 Eniricerche Spa Coniugato peptidico immunologicamente attivo utile come vaccino antimalaria e metodo di immunizzazione impiegante lo stesso
US5231168A (en) * 1988-09-16 1993-07-27 Statens Seruminstitut Malaria antigen
CA2006700A1 (en) * 1989-01-17 1990-07-17 Antonello Pessi Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
IT1237764B (it) * 1989-11-10 1993-06-17 Eniricerche Spa Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
IT1241395B (it) * 1990-04-02 1994-01-10 Eniricerche Spa Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria
JP2586960B2 (ja) * 1991-01-25 1997-03-05 日産建設株式会社 岩盤竪坑築造のための無発破式工法及びこの工法に使用する装置
JPH10204358A (ja) * 1996-11-21 1998-08-04 Brother Ind Ltd ホットメルト型固体インク

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
CN86100979A (zh) * 1985-02-07 1986-12-17 史密丝克莱恩贝克曼公司 疟疾疫苗的制备方法
ATE78869T1 (de) * 1985-02-07 1992-08-15 Smithkline Beecham Corp Malaria-impfstoff.
PT82282B (pt) * 1985-03-28 1988-02-17 Univ New York Processo de preparacao de um conjugado de proteina de suporte-antigeno imunogenico para uso como vacina contra malaria

Also Published As

Publication number Publication date
CA1339590C (en) 1997-12-16
JPH0772198B2 (ja) 1995-08-02
BR8603729A (pt) 1987-03-10
DE3685917D1 (de) 1992-08-13
JPS6229597A (ja) 1987-02-07
ATE77957T1 (de) 1992-07-15
EP0209643B1 (en) 1992-07-08
IN162809B (es) 1988-07-09
IT8521718A0 (it) 1985-07-25
ES8707262A1 (es) 1987-07-16
ES555886A0 (es) 1987-07-16
DE3685917T2 (de) 1993-02-25
EP0209643A3 (en) 1988-07-06
EP0209643A2 (en) 1987-01-28
IT1187710B (it) 1987-12-23

Similar Documents

Publication Publication Date Title
AR247404A1 (es) Composicion peptidica de uso exclusivo para el diagnostico de la enfermedad de la malaria y procedimiento de sintesis de dicha composicion peptidica
NO20073429L (no) Anvendelse av et antistoff mot interleukin-6-reseptor for fremstilling av et farmasoytisk preparat
CY1112139T1 (el) Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης
ES2084579T3 (es) Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
ES2052594T3 (es) Nuevos compuestos polihidroxilados y altamente fluorados, su preparacion y su uso como tensioactivos.
KR880004807A (ko) 수산화알루미늄을 함유하는 이부프로펜 조성물
ATE50260T1 (de) Purinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
AU8172094A (en) Synthetic HTLV-III peptides, compositions and uses thereof
ATE33635T1 (de) Substituierte sulfonamidbenzamide, antiarythmische mittel und deren zusammensetzungen.
BR9813651A (pt) Compostos antipicornavirais e métodos para o seu uso e preparação
ES2028796T3 (es) Procedimiento para producir preparados farmaceuticos que contienen interferon alfa.
KR880007514A (ko) 키놀린 화합물
IT1212900B (it) Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna
DE69033745D1 (de) Oberflächenaktive zusammensetzungen und verfahren
ATE220912T1 (de) Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung
DE69530380D1 (de) Retropeptide, antikörper dagegen und deren verwendungen in der impfung und in vitro diagnostik
ATE93388T1 (de) Paracetamol enthaltende arzneizubereitung.
DK527186D0 (da) Bronchodilaterende farmaceutisk praeparat
BR9612422A (pt) Pseudo-partìculas virais recombinantes, composição, utilização de pseudo-partìculas, e, processo de estimulação in vitro de respostas t citotóxicas de linfócitos provenientes de indivìduos atingidos por infecções virais ou tumorais.
EP0353474A3 (en) Glycerin derivative and its pharmacological use
EP0209843A3 (en) Benzylpiperazine compound, preparation thereof, pharmaceutical composition, and use
SE8704240D0 (sv) Analgesic preparations
EP0218953A3 (en) Derivatives of 19,20-bis-nor-prostanoic acid with antiulcer and anorectic activity, process for their preparation and pharmaceutical compositions thereof
CA2010022A1 (en) Anesthetic oral compositions
ATE57692T1 (de) Chemische verbindung mit antimykotischer, vernarbungsfoerdernder und entzuendungshemmender wirkung.